Pancreastatin—A Novel Regulatory Peptide?

References

• Tatemoto K, Efendic S, Mutt V, Makk G, Feistner G J, Barchas JD. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986; 324: 476–8
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Mutt V. Chemical determination of polypeptide hormones. Proc Natl Acad Sci USA 1978; 75: 4115–9
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Mutt V. Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon-secretin family. Proc Natl Acad Sci USA 1981; 78: 6603–7
   PubMed Web of Science ®Google Scholar
• Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 1982; 79: 5485–9
   PubMed Web of Science ®Google Scholar
• Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 1982; 79: 2514–8
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y—a novel brain peptide with structural similarities to- peptide YY and pancreatic polypeptide. Nature 1982; 296: 659–60
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Rokaeus A, Jornvall H, McDonald T J, Mutt V. Galan In: a novel biologically active peptide from porcine intestine. FEBS Lett 1983; 164: 124–8
   PubMed Web of Science ®Google Scholar
• Benedum U M, Baeuerle P A, Konecki D S, et al. The primary structure of bovine chromogranin A: a representative of a class of acidic secretory proteins common to a variety of peptidergic cells. EMBO J 1986; 5: 1495–502
   PubMed Web of Science ®Google Scholar
• Iacangelo A, Affolter H U, Eiden L E, Herbert E, Grimes M. Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature 1986; 323: 82–6
   PubMed Web of Science ®Google Scholar
• Ahn T G, Cohn D V, Gorr S U, Ornstein D L, Kashdan M A, Levine MA. Primary structure of bovine pituitary secretory protein I (chromogranin A) deduced from the cDNA sequence. Proc Natl Acad Sci USA 1987; 84: 5043–7
   PubMed Web of Science ®Google Scholar
• Huttner W B, Benedum UM. Chromogranin A and pancreastatin. Nature 1987; 325: 305
   PubMed Web of Science ®Google Scholar
• Eiden LE. Is chromogranin a prohormone?. Nature 1987; 325: 301
   PubMed Web of Science ®Google Scholar
• Iacangelo A L, Fischer-Colbrie R, Roller K J, Brownstein M J, Eiden LE. The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin. Endocrinology 1988; 155: 2339–41
   Google Scholar
• Konecki D S, Benedum U M, Gerdes H H, Huttner WB. The primary structure of human chromogranin A and pancreastatin. J Biol Chem 1987; 262: 17026–30
   PubMed Web of Science ®Google Scholar
• Helman L J, Ahn T G, Levine M A, et al. Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. J Biol Chem 1988; 263: 11559–63
   PubMed Web of Science ®Google Scholar
• Schmidt W E, Siegel E G, Kratzin H, Creutzfeldt W. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad Sci USA 1988; 85: 8231–5
   PubMed Web of Science ®Google Scholar
• Sekiya K, Ghatei M A, Minamino N, Bretherton-Watt D, Matsuo H, Bloom SR. Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma. FEBS Lett 1988; 228: 153–6
   PubMed Web of Science ®Google Scholar
• Funakoshi S, Tamamura H, Ohta M, et al. Isolation and characterization of a tumor-derived human pancreastatin-related protein. Biochem Biophys Res Commun 1989; 164: 141–8
   PubMed Web of Science ®Google Scholar
• Hutton J C, Davidson H W, Grimaldi K A, Pershavaria M. Biosynthesis of betagranin in pancreatic B-cells. Biochem J 1987; 244: 449–56
   PubMedGoogle Scholar
• Hutton J C, Davidson H W, Peshavaria M. Proteolytic processing of chromogranin A in purified insulin granules. Biochem J 1987; 244: 457–64
   PubMedGoogle Scholar
• Hutton J C, Hansen F, Peshavaria M. B-Granins: 21KDa cosecreted peptides of the insulin granule closely related to adrenal medullary chromogranin. FEBS Lett 1987; 188: 336–40
   Web of Science ®Google Scholar
• Nakano I, Funakoshi A, Miyasaka K, et al. Isolation and characterization of bovine pancreastatin. Regul Pept 1989; 25: 207–13
   PubMedGoogle Scholar
• Iacangelo A, Okayama H, Eiden LE. Primary structure of rat chromogranin A and distribution of its mRNA. FEBS Lett 1988; 227: 115–21
   PubMed Web of Science ®Google Scholar
• Hutton J C, Nielsen E, Kastern W. The molecular cloning of the chromogranin A-like precursor of beta-granin and pancreastatin from the endocrine pancreas. FEBS Lett 1988; 236: 269–74
   PubMed Web of Science ®Google Scholar
• Parmer R J, Koop A H, Handa M T, O'Connor DT. Molecular cloning of chromogranin A from rat pheochromocytoma cells. Hypertension 1989; 14: 435–44
   PubMed Web of Science ®Google Scholar
• Abood M E, Eberwine JH. Characterization and regulation of a cDNA clone for rat pancreastatin. Biochem Biophys Res Commun 1990; 167: 1079–85
   PubMed Web of Science ®Google Scholar
• Cohn D V, Fasciotto B H, Gorr S U, et al. The putative role of secretory protein-I/chromogranin A as a precursor for regulatory hormones. Prog Clin Biol Res 1990; 332: 51–66
   PubMedGoogle Scholar
• Rosa P, Hille A, Lee R WH, Zaini A, De Camilli P, Huttner WB. Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway. J Cell Biol 1985; 101: 1999–2011
   PubMed Web of Science ®Google Scholar
• Helle K B, Reed R K, Ehrhart M, Aunis D., Hogue-Angeletti R. Chromogranin A: osmotically active fragments and their susceptibility to proteolysis during lysis of the bovine chromaffin granules. Acta Physiol Scand 1990; 138: 565–74
   PubMedGoogle Scholar
• Leduc R, Hendy G N, Seidah N G, Chretien M, Lazure C. Fragmentation of bovine chromogranin A by plasma kallikrein. Life Sci 1990; 46: 1427–33
   PubMed Web of Science ®Google Scholar
• Settleman J, Fonseca R, Nolan J, Angeletti RH. Relationship of multiple forms of chromogranins. J Biol Chem 1985; 260: 1645–51
   PubMed Web of Science ®Google Scholar
• Schmidt W E, Siegel E G, Lamberts R, Gallwitz B, Creutzfeldt W. Pancreastat In: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues. Endocrinology 1988; 123: 1395–404
   PubMed Web of Science ®Google Scholar
• Buffa R, Gini A, Pelagi M, et al. Immunoreactivity of hormonally-characterized human endocrine cells against three novel anti-human chromogranin B (Bll and B13) and chromogranin A (All) monoclonal antibodies. Arch Histol Cytol 1989; 52: 99–105, Suppl.
   PubMedGoogle Scholar
• Lamberts R, Schmidt W E, Creutzfeldt W. Light and electron microscopical immunocytochemical localization of pancreastatin-like immunoreactivity in porcine tissues. Histochem 1990; 93: 369–80
   Google Scholar
• Bretherton-Watt D, Ghatei M A, Bishop A E, et al. Pancreastatin distribution and plasma levels in the pig. Peptides 1988; 9: 1005–14
   PubMed Web of Science ®Google Scholar
• Ravazzola M, Efendic S, Ostenson C G, Tatemoto K, Hutton J C, Orci L. Localization of pancreastatin immunoreactivity in porcine endocrine cells. Endocrinology 1988; 123: 227–9
   PubMed Web of Science ®Google Scholar
• Bishop A E, Bretherton-Watt D, Hamid Q A, et al. The occurrence of pancreastatin in tumors of the diffuse neuroendocrine system. Mol Cell Probes 1988; 2: 225–35
   PubMed Web of Science ®Google Scholar
• Kar S, Bretherton-Watt D, Gibson S J, et al. Novel peptide pancreastat In: its occurrence and codistribution with chromogranin A in the central nervous system of the pig. J Comp Neurol 1989; 288: 627–39
   PubMed Web of Science ®Google Scholar
• Hartschuh W, Weihe E. Pancreastatin-like immunoreactivity in epidermal Merkel cells of pig and man. Neurosci Lett 1989; 98: 258–63
   PubMed Web of Science ®Google Scholar
• Östenson C O, Efendic S, Hoist JJ. Pancreastatin-like immunoreactivity and insulin are released in parallel from the perfused porcine pancreas. Endocrinology 1989; 124: 2986–90
   PubMed Web of Science ®Google Scholar
• Tateishi K, Funakoshi A, Jimi A, et al. High plasma pancreastatin-like immunoreactivity in a patient with malignant insulinoma. Gastroenterology 1989; 97: 1313–18
   PubMed Web of Science ®Google Scholar
• Tateishi K, Funakoshi A, Wakasugi H, et al. Plasma pancreastatin-like immunoreactivity in various diseases. J Clin Endocrinol Metab 1989; 69: 1305–8
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Tateishi K, Shinozaki H, Miyasaka K, Ito T, Wakasugi H. Plasma pancreastatin responses after intrajejunal infusion of liquid meal in patients with chronic pancreatitis. Dig Dis Sci 1990; 35: 721–5
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Tateishi K, Tsuru M, et al. Pancreastatin producing cell line from human pancreatic islet cell tumor. Biochem Biophys Res Commun 1990; 168: 741–6
   PubMed Web of Science ®Google Scholar
• Efendic S, Tatemoto K, Mutt V, Quan C, Chang D, Östenson CG. Pancreastatin and islet hormone release. Proc Natl Acad Sci USA 1987; 84: 7257–60
   PubMed Web of Science ®Google Scholar
• Silvestre R A, Peiro E, Miralles P, Villanueva M L, Marco J. Effects of pancreastatin on insulin, glucagon and somatostatin secretion by the perfused rat pancreas. Life Sci 1988; 42: 1361–7
   PubMed Web of Science ®Google Scholar
• Ahren B, Lindskog S, Tatemoto K, Efendic S. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 1988; 37: 281–5
   PubMed Web of Science ®Google Scholar
• Östenson C G, Sandler S, Efendic S. Effects of porcine pancreastatin on secretion and biosynthesis of insulin and glucose oxidation of isolated rat pancreatic islets. Pancreas 1989; 4: 441–6
   PubMed Web of Science ®Google Scholar
• Lindskog S, Ahren B. Galanin and pancreastatin inhibit stimulated insulin secretion in the mouse: comparison of effects. Horm Res 1988; 29: 237–40
   PubMedGoogle Scholar
• Schmidt W E, Binder G, Gallwitz B, Siegel E G, Creutzfeldt W. C-terminal fragments of pancreastatin inhibit GIP-induced insulin secretion in isolated rat pancreatic islets. Diabetologia 1987; 30: A579
   Web of Science ®Google Scholar
• Peiro E, Miralles P, Silvestre R A, Villanueva M L, Marco J. Pancreastatin inhibits insulin secretion as induced by glucagon, vasoactive intestinal peptide, gastric inhibitory peptide, and 8-cholecystokinin in the perfused rat pancreas. Metabolism 1989; 38: 679–82
   PubMed Web of Science ®Google Scholar
• Ishizuka J, Singh P, Greeley GH., Jr., et al. A comparison of the insulinotropic and the insulin-inhibitory actions of gut peptides on newborn and adult rat islet cells. Pancreas 1988; 3: 77–82
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Jimi A, Yasunami Y, et al. Bioactivity of human pancreastatin and its localization in pancreas. Biochem Biophys Res Commun 1989; 159: 913–8
   PubMed Web of Science ®Google Scholar
• Lorinet A M, Tatemoto K, Laburthe M, Amiranof TB. Pancreastatin inhibits insulin release from RIN m 5F cells: reversion by pertussis toxin. Eur J Pharmacol 1989; 160: 405–7
   PubMed Web of Science ®Google Scholar
• Greeley GH, Jr., Thompson J C, Ishizuka J, et al. Inhibition of glucose-stimulated insulin release in the perfused rat pancreas by parathyroid secretory protein-I (chromogranin-A). Endocrinology 1989; 124: 1235–8
   PubMed Web of Science ®Google Scholar
• Ohneda A, Koizumi F, Ohneda M. Effect of porcine pancreastatin on endocrine function of canine pancreas. Tohoku J Exp Med 1989; 159: 291–8
   PubMed Web of Science ®Google Scholar
• Inui A, Okita M, Inoue T, et al. Effects of pancreastatin on insulin and pancreatic polypeptide secretion in the dog. Endocrinol Jpn 1989; 36: 733–8
   PubMedGoogle Scholar
• Holst J J, Östenson C-G, Harling H, Messell T. Porcine pancreastatin has no effect on endocrine secretion from the pig pancreas. Diabetologia 1990; 33: 403–6
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Miyasaka K, Kitani K, Tatemoto K. Effect of pancreastatin on pancreatic endocrine function in the conscious rat. Regul Pept 1989; 24: 225–31
   PubMedGoogle Scholar
• Funakoshi A, Miyasaka K, Kitani K, Tamamura H, Funakoshi S, Yajima H. Bioactivity of synthetic C-terminal fragment of rat pancreastatin on endocrine pancreas. Biochem Biophys Res Commun 1989; 158: 844–9
   PubMed Web of Science ®Google Scholar
• Sanchez V, Calvo J R, Goberna R. Glycogenolytic effect of pancreastatin in the rat. Biosci Rep 1990; 10: 87–91
   PubMed Web of Science ®Google Scholar
• Gunion M W, Rosenthal M J, Tatemoto K, Morley JE. Intracranial microinfusion of pancreastatin elevates blood glucose, free fatty acids, and corticosterone in rats. Brain Res 1989; 485: 251–7
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Miyasaka K, Nakamura R, et al. Bioactivity of synthetic human pancreastatin on exocrine pancreas. Biochem Biophys Res Commun 1988; 156: 1237–42
   PubMed Web of Science ®Google Scholar
• Ishizuka J, Asada I, Poston G J, et al. Effect of pancreastatin on pancreatic endocrine and exocrine secretion. Pancreas 1989; 4: 277–81
   PubMed Web of Science ®Google Scholar
• Funakoshi A, Miyasaka K, Nakamura R, Kitani K, Tatemoto K. Inhibitory effect of pancreastatin on pancreatic exocrine secretion in the conscious rat. Regul Pept 1989; 25: 157–66
   PubMedGoogle Scholar
• Funakoshi A, Miyasaka K, Kitani K, et al. Comparative effects of mammalian pancreastatins on the pancreatic exocrine secretion. Jpn J Physiol 1989; 39: 901–5
   PubMedGoogle Scholar
• Miyasaka K, Funakoshi A, Kitani K, Tamamura H, Fujii N, Funakoshi S. The importance of the C-terminal amide structure of rat pancreastatin to inhibit pancreatic exocrine secretion. FEBS Lett 1990; 263: 279–80
   PubMed Web of Science ®Google Scholar
• Miyasaka K, Funakoshi A, Yasunami Y, et al. Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats. Regul Pept 1990; 28: 189–98
   PubMedGoogle Scholar
• Miyasaka K, Funakoshi A, Nakamura R, Kitani K, Shimizu F, Tatemoto K. Effects of porcine pancreastatin on postprandial pancreatic exocrine secretion and endocrine functions in the conscious rat. Digestion 1989; 43: 204–11
   PubMed Web of Science ®Google Scholar
• Lewis J J, Zdon M J, Adrian T E, Modlin IM. Pancreastat In: a novel peptide inhibitor of parietal cell secretion. Surgery 1988; 104: 1031–6
   PubMed Web of Science ®Google Scholar
• Lewis J J, Goldenring J R, Asher V A, Modlin IM. Pancreastat In: a novel peptide inhibitor of parietal cell signal transduction. Biochem Biophys Res Commun 1989; 163: 667–73
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Kogire M, Lluis F, et al. Stimulatory effect of pancreastatin on gastric acid secretion in conscious dogs. Gastroenterology 1990; 99: 61–5
   PubMed Web of Science ®Google Scholar
• Fasciotto B H, Gorr S U, DeFranco D J, Levine M A, Conn DV. Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture. Endocrinology 1989; 125: 1617–22
   PubMed Web of Science ®Google Scholar
• Schmidt W E, Stöckmann F, Roy Choudhury A, et al. Influence of CCK antagonist L-364, 718, pancreastatin (33–49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy. Digestion 1989; 44: 105–16
   PubMed Web of Science ®Google Scholar
• Flood J F, Morley J E, Tatemoto K. Effects of systemic pancreastatin on memory retention. Peptides 1988; 9: 1077–80
   PubMed Web of Science ®Google Scholar
• Blaschko H, Comline R S, Schneider F H, Silver M, Smith AD. Secretion of a chromaffine granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 1967; 215: 58–61
   PubMed Web of Science ®Google Scholar
• Reiffen F U, Gratzl M. Chromogranins, widespread in endocrine and nervous tissue, bind Ca2′. FEBS Lett 1986; 195: 327–30
   PubMed Web of Science ®Google Scholar
• Seidah N G, Hendy G N, Hamelin J, et al. Chromogranin A can act as a reversible processing enzyme inhibitor. FEBS Lett 1987; 211: 144–50
   PubMed Web of Science ®Google Scholar
• Grossman MI. Gastrointestinal hormones: spectrum of actions and structure-activity relations. Endocrinology of the gut, W Y Chey, F P Brooks. Charles B. Slack, Thorofare, New Jersey 1974; 65–81
   Google Scholar
• Rehfeld JF. Gastrointestinal hormones and insulin secretion. Scand J Gastroent 1972; 7: 289–99
   PubMed Web of Science ®Google Scholar
• Creutzfeldt W. Effects of gastrointestinal hormones—physiological or pharmacological?. Stimulus-secretion coupling in the gastriointestinal tract, R M Case, H Goebell. MTP, Lancaster 1976; 415–28
   Google Scholar
• Schally A V, Huang W Y, Redding T W, et al. Isolation, structural elucidation and synthesis of a tetradecapeptide with in vitro ACTH-releasing activity corresponding to residues 33–46 of the alpha-chain of porcine hemoglobin. Biochem Bio-phys Res Commun 1978; 82: 582–8
   PubMed Web of Science ®Google Scholar
• Kiso Y, Kitagawa K, Kawai N, et al. Neo-kyotorphin (Thr-Ser-Lys-Tyr-Arg), a new analgesic peptide. FEBS Lett 1983; 155: 281–4
   PubMed Web of Science ®Google Scholar